DE2365992C3 - 6α-Fluor-17,21-dihydroxy-16β-methylpregna-4,9(11)-dien-3,20-dion-17,21-diacetat und Verfahren zu dessen Herstellung - Google Patents

6α-Fluor-17,21-dihydroxy-16β-methylpregna-4,9(11)-dien-3,20-dion-17,21-diacetat und Verfahren zu dessen Herstellung

Info

Publication number
DE2365992C3
DE2365992C3 DE2365992A DE2365992A DE2365992C3 DE 2365992 C3 DE2365992 C3 DE 2365992C3 DE 2365992 A DE2365992 A DE 2365992A DE 2365992 A DE2365992 A DE 2365992A DE 2365992 C3 DE2365992 C3 DE 2365992C3
Authority
DE
Germany
Prior art keywords
dione
diene
fluoro
methylpregna
dihydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2365992A
Other languages
German (de)
English (en)
Other versions
DE2365992B2 (de
DE2365992A1 (de
Inventor
Carl Alvin Kalamazoo Mich. Schlagel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DE2365992A1 publication Critical patent/DE2365992A1/de
Publication of DE2365992B2 publication Critical patent/DE2365992B2/de
Application granted granted Critical
Publication of DE2365992C3 publication Critical patent/DE2365992C3/de
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2365992A 1972-03-09 1973-02-22 6α-Fluor-17,21-dihydroxy-16β-methylpregna-4,9(11)-dien-3,20-dion-17,21-diacetat und Verfahren zu dessen Herstellung Expired DE2365992C3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23333772A 1972-03-09 1972-03-09
US31697372A 1972-12-20 1972-12-20

Publications (3)

Publication Number Publication Date
DE2365992A1 DE2365992A1 (de) 1977-05-18
DE2365992B2 DE2365992B2 (de) 1981-08-06
DE2365992C3 true DE2365992C3 (de) 1982-05-19

Family

ID=26926821

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2365992A Expired DE2365992C3 (de) 1972-03-09 1973-02-22 6α-Fluor-17,21-dihydroxy-16β-methylpregna-4,9(11)-dien-3,20-dion-17,21-diacetat und Verfahren zu dessen Herstellung

Country Status (13)

Country Link
JP (3) JPS5331156B2 (US07118763-20061010-C00002.png)
AR (1) AR197216A1 (US07118763-20061010-C00002.png)
AU (1) AU468257B2 (US07118763-20061010-C00002.png)
CH (3) CH580118A5 (US07118763-20061010-C00002.png)
DE (1) DE2365992C3 (US07118763-20061010-C00002.png)
DK (1) DK133382B (US07118763-20061010-C00002.png)
ES (1) ES412235A1 (US07118763-20061010-C00002.png)
FR (1) FR2181802B1 (US07118763-20061010-C00002.png)
GB (1) GB1403962A (US07118763-20061010-C00002.png)
HK (1) HK62680A (US07118763-20061010-C00002.png)
NL (1) NL165178C (US07118763-20061010-C00002.png)
PH (1) PH14703A (US07118763-20061010-C00002.png)
SE (1) SE396756B (US07118763-20061010-C00002.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1430223A (en) * 1973-10-25 1976-03-31 Upjohn Co Anti-inflammatory composition comprising steroids
ZA77943B (en) * 1976-03-19 1977-12-28 Upjohn Co Topical steroid clindamycin preparations
NL187577C (nl) * 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
DE3068965D1 (en) 1979-11-16 1984-09-20 Sterosynt Ltd 6-alpha-fluoro-16-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them
JPH0240957Y2 (US07118763-20061010-C00002.png) * 1986-08-30 1990-10-31

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB933859A (US07118763-20061010-C00002.png) * 1958-09-06 1963-08-14 Syntex S.A.

Also Published As

Publication number Publication date
JPS5344465B2 (US07118763-20061010-C00002.png) 1978-11-29
NL165178B (nl) 1980-10-15
JPS5227761A (en) 1977-03-02
DE2365992B2 (de) 1981-08-06
NL7303262A (US07118763-20061010-C00002.png) 1973-09-11
AR197216A1 (es) 1974-03-22
CH580117A5 (US07118763-20061010-C00002.png) 1976-09-30
DE2365992A1 (de) 1977-05-18
ES412235A1 (es) 1976-01-01
GB1403962A (en) 1975-08-28
HK62680A (en) 1980-11-14
PH14703A (en) 1981-11-10
JPS5227760A (en) 1977-03-02
FR2181802B1 (US07118763-20061010-C00002.png) 1976-10-22
SE396756B (sv) 1977-10-03
DK133382B (da) 1976-05-10
NL165178C (nl) 1981-03-16
AU5257973A (en) 1974-08-29
CH580118A5 (US07118763-20061010-C00002.png) 1976-09-30
JPS5344464B2 (US07118763-20061010-C00002.png) 1978-11-29
DK133382C (US07118763-20061010-C00002.png) 1976-10-04
JPS5331156B2 (US07118763-20061010-C00002.png) 1978-08-31
JPS4899157A (US07118763-20061010-C00002.png) 1973-12-15
CH580116A5 (US07118763-20061010-C00002.png) 1976-09-30
FR2181802A1 (US07118763-20061010-C00002.png) 1973-12-07
AU468257B2 (en) 1976-01-08

Similar Documents

Publication Publication Date Title
DE2655570A1 (de) Neue polyhalogensteroide und verfahren zu ihrer herstellung
CH533094A (de) Verfahren zur Herstellung neuer Steroide
DE2913147C2 (US07118763-20061010-C00002.png)
CH629825A5 (de) Verfahren zur herstellung von terpenoiden estern von steroiden der pregnanreihe.
DE2365992C3 (de) 6α-Fluor-17,21-dihydroxy-16β-methylpregna-4,9(11)-dien-3,20-dion-17,21-diacetat und Verfahren zu dessen Herstellung
DE2538595A1 (de) Steroidverbindungen
CH644614A5 (de) 17-alpha-acyloxy-5-beta- und 17-alpha-acyloxy-5-alpha-corticoide.
CH505802A (de) Verfahren zur Herstellung von Estern von 17a-Hydroxysteroiden der Pregnanreihe
DE3109459A1 (de) (delta)(pfeil hoch)9(pfeil hoch)(pfeil hoch)((pfeil hoch)(pfeil hoch)1(pfeil hoch)(pfeil hoch)1(pfeil hoch)(pfeil hoch))(pfeil hoch)- und (delta)(pfeil hoch)1(pfeil hoch)(pfeil hoch)6(pfeil hoch)-21-chlor-20-keto-steroide der pregnan- und d-homo-pregnan-reihe, verfahren zu ihrer herstellung und ihre verwendung als zwischenprodukte fuer die synthese von hochwirksamen corticoiden
CH537917A (de) Verfahren zur Herstellung von 20-Hydroperoxysteroiden
DE2852055C2 (US07118763-20061010-C00002.png)
DE2603545C3 (de) Neue 16 a -Methyl-17 a - brom-prednisolon- und prednisonderivate und Verfahren zu deren Herstellung
DE2448662C2 (de) 6α-Fluor-16α-methyl-1,4,8-pregnatrien-3,20-dion-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP0077541A1 (de) Delta-1,3,5-3-Chlor-11-Beta,16-Alpha,17-Alpha,21-tetra-(hydroxy)-pregnan-20-on-16,17-acetonidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2630270A1 (de) 21-acetale und gemischte 21-acetale von steroid-21-aldehyden, zwischenprodukte und verfahren zur herstellung derselben
DE2904614A1 (de) Chlormethyl-17 alpha -acetoxy- 9 alpha -fluor-11 beta -hydroxy-16 beta -methyl-3-oxoandrosta-1,4-dien-17 beta -carboxylat, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zusammensetzungen
DE1568971C3 (de) Steroidoxazoline und Verfahren zu ihrer Herstellung
DE1593518C3 (de) Verfahren zur Herstellung eines 17 alpha-Esters der Pregnanreihe
DE2204360C2 (de) Neue Pregnansäure-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
EP0040355B1 (de) Verfahren zur partiellen Reduktion von C21-Steroidcarbonsäuren und ihren Estern zu C21-Steroidalkoholen
DD229702A5 (de) Verfahren zur herstellung von neuen corticoidderivaten
DE2508136C3 (de) Neue Steroide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
CH625254A5 (US07118763-20061010-C00002.png)
DE1568951C (de) Steroid- eckige Klammer auf 17 alpha, 16 alpha-d eckige Klammer zu -oxazoline und ein Verfahren zu deren Herstellung
DE1493313C (de) 16b, 17 Cycloenolather des 17alpha Hydroxy öalpha methyl 3,20 dioxo 4 pregnen 16alpha acetaldehyds und des 1 lbeta, 17alpha Dihydroxy 9alpha fluor 6alpha methyl 3,20 dioxo 1,4 pregnadien 16alpha acetaldehyds und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
OD Request for examination
AC Divided out of

Ref country code: DE

Ref document number: 2308731

Format of ref document f/p: P

C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee